Supplementary Tables 1 from A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

<p>Supplementary TablesSupplementary Table 1: Patient and tumor sample informationSupplementary Table 2: Tumor mutation burdenSupplementary Table 3: Unfiltered whole exome sequencing mutation analysisSupplementary Table 4: Filtered whole exome sequencing mutation analysisSupplementary Table 5:...

全面介紹

Saved in:
書目詳細資料
主要作者: H. Josh Jang (15206898) (author)
其他作者: Galen Hostetter (15053070) (author), Alexander W. Macfarlane (15206901) (author), Zachary Madaj (15206904) (author), Eric A. Ross (15019395) (author), Toshinori Hinoue (15206907) (author), Justin R. Kulchycki (15206910) (author), Ryan S. Burgos (15206913) (author), Mahvish Tafseer (15206916) (author), R. Katherine Alpaugh (15206919) (author), Candice L. Schwebel (15206922) (author), Rutika Kokate (15206925) (author), Daniel M. Geynisman (15206928) (author), Matthew R. Zibelman (15206931) (author), Pooja Ghatalia (15206934) (author), Peter W. Nichols (15206937) (author), Woonbok Chung (15206940) (author), Jozef Madzo (14923007) (author), Noah M. Hahn (15206943) (author), David I. Quinn (15012291) (author), Jean-Pierre J. Issa (15109358) (author), Michael J. Topper (15206946) (author), Stephen B. Baylin (15045804) (author), Hui Shen (10996894) (author), Kerry S. Campbell (9724036) (author), Peter A. Jones (14941116) (author), Elizabeth R. Plimack (15044781) (author)
出版: 2025
主題:
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!